Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Autonomic Technologies
Redwood City, California, United Statesrealeve.net ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
The Pulsante microstimulator has CE mark approval in Europe for the treatment of cluster headaches and was under an Investigational Device Exemption (IDE) study in the US for chronic cluster headache. The company developed miniaturized neurostimulation devices targeting the sphenopalatine ganglion to treat severe headaches[1][2].
- Therapeutic areas
- Neurology
- Modalities
- DeviceNeurostimulation device
- Industry
- Therapeutic Medical Devices
02
Partnerships
Not specified in available sources.
Beyond the preview
Go deeper on Autonomic Technologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Autonomic Technologies.